Corporate Sponsors

Corporate Sponsorship provides yearly support to the Canadian Rheumatology Association (CRA) so that we may further our mission to represent Canadian Rheumatologists and promote the pursuit of excellence in arthritis and rheumatic disease care, education, and research. The sponsorship supports CRA members including clinicians, students, allied health professionals and researchers through funding CRA’s various programs and initiatives, including educational offerings, networking events, training sessions and more (Annual Scientific Meeting (ASM) included).

CRA recognizes our valued Corporate Sponsors at the ASM, as well as on CRA’s website, in the Annual Report, and at functions including the Canada Night reception at ACR and Industry Roundtable meeting.

Depending on the level of sponsorship, there are various opportunities available to Corporate Sponsors, including:

  • Hosting a symposium at the ASM (available to Diamond and Platinum sponsors only).
  • An allowance for attendance at the ASM and Canada Night at ACR.
  • Proposing special projects that align with CRA’s mission and strategic priorities.

In addition to Corporate Sponsorship, organizations may be interested in supporting CRA by exhibiting at the ASM. Exhibitors will have the opportunity to showcase their offerings, interact with CRA members and demonstrate their support for the rheumatology community at a dynamic multi-day educational and networking event that fosters professional collaboration and an exchange of ideas in the rheumatology community.

The Canadian Rheumatology Association would like to thank all of our corporate sponsors for their support in 2020.

Read the CRA’s Industry Guidelines

Diamond

AbbVie Corporation

Novartis Pharmaceuticals Canada Inc.

Pfizer Canada

Platinum

Amgen Canada

Boehringer Ingelheim

Gilead

Janssen Inc.

Gold

Bristol-Myers Squibb Canada

Eli Lilly Canada

Sandoz Canada Inc.

UCB Canada Inc.

Silver

Medexus Inc.

Merck Canada

Roche Canada

Sanofi Genzyme

Sobi Canada, Inc.

Bronze

Mallinckrodt Pharmaceuticals